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In this study, genetic analysis was conducted to investigate the association of angiotensin I converting enzyme (ACE) gene
polymorphismwithclinicalphenotypebasedondiﬀerentiation-syndromeofbronchialasthmapatients.Diﬀerentiation-syndrome
is a traditional Korean medicine (TKM) theory in which patients are classiﬁed into a Deﬁciency Syndrome Group (DSG) and an
Excess Syndrome Group (ESG) according to their symptomatic classiﬁcation. For this study, 110 participants were evaluated by
pulmonary function test. Among them, 39 patients were excluded because they refused genotyping. Of the remaining patients,
52 with DSG of asthma (DSGA) and 29 with ESG of asthma (ESGA), as determined by the diﬀerentiation-syndrome techniques
were assessed by genetic analysis. ACE insertion/deletion (I/D) polymorphism analysis was conducted using polymerase chain
reaction (PCR).Student’s t, chi-square, Fisher andHardy-Weinberg equilibrium tests were used to compare groups. No signiﬁcant
diﬀerences in pulmonary function were observed between DSGA and ESGA. The genotypic frequency of ACE I/D polymorphism
wasfoundtodiﬀerslightlybetween DSGAandESGA(P=.0495).However,therewerenosigniﬁcantdiﬀerences inallelicfrequency
observed between DSGA and ESGA (P = .7006, OR = 1.1223). Interestingly, the allelic (P = .0043, OR = 3.4545) and genotypic
(P = .0126) frequencies of the ACE I/D polymorphism in female patients diﬀered signiﬁcantly between DSGA and ESGA. Taken
together, the results presented here indicate that the symptomatic classiﬁcation of DSGA and ESGA by diﬀerentiation-syndrome
in Korean asthma patients could be useful in evaluation of the pathogenesis of bronchial asthma.
1.Introduction
Asthma is a chronic inﬂammatory disease characterized by
airwayinﬂammation, increasedmucusproduction,intermit-
tent airway obstruction, and increased responsiveness [1–
4]. The angiotensin I converting enzyme (ACE) inactivates
bradykinin and tachykinins such as neurokinin A and
substance P, which play important roles in asthma. Patients
with asthma reportedly have bronchial hyper-reactivity to
bradykinin when compared to control groups [5].
The ACE gene is located in the chromosome 17q23
region. Individual variability in the plasma ACE is associated
with an insertion/deletion (I/D) polymorphism involving a
250-bp region situated in intron 16 of the ACE gene, which
is known as the ACE I/D polymorphism [6]. According to
the available medical literature, asthma patients in France
are characterized by a higher prevalence of the ACE D/D
genotype[7]. However,thedistribution ofthe ACEgenotype
did not diﬀer signiﬁcantly between Turkish asthma patients
and a control group [8]. Conversely, a signiﬁcant association
of the ACE I/D polymorphism with asthma was reported in
asthma patients from the Czech Republic [9].
Traditional Korean medicine (TKM) uses a unique
diagnostic technique known as diﬀerentiation-syndrome to2 Evidence-Based Complementary and Alternative Medicine
analyze signs and symptoms of patients. In TKM, it is
possible to have various treatments for the same disease
because diﬀerentiation-syndromes are based on the overall
analysis of symptoms and signs, causes, nature and the
location of the illness. Wu and Guo [10]r e p o r t e dt h a t
chronic glomerulonephritis and diﬀerentiation-syndromes
wererelatedtocytochemicalchangesintheperipheralblood.
In addition, Ji et al. [11] reported that 90 patients with
chronic atrophic gastritis were divided into six groups by
diﬀerentiation-syndrome. Wang et al. [12]r e p o r t e dt h e
eﬀects of planning treatments according to diﬀerentiation-
syndrome.
Using diﬀerentiation-syndrome, asthma patients can be
divided into two groups, the Deﬁciency Syndrome Group of
Asthma (DSGA) and an Excess Syndrome Group of Asthma
(ESGA). Deﬁciency refers to a deﬁciency of genuine Qi,
lowered body resistance and declining function, including
Yin and Yang-deﬁciency. Excess is characterized by the
presence of excessive pathogenic factors that lead to an
intense body reaction, or by the presence of pathological
products due to the dysfunction of internal organs, such as
stagnant Qi and blood, excessive ﬂuid, retained phlegm and
undigested food.
This study was conducted to determine if ACE I/D
polymorphism was associated with a clinical phenotype of
DSGA or ESGA in asthma patients. To accomplish this, we
classiﬁed asthma patients into DSGA or ESGA categories
and then analyzed the patients for the presence of ACE I/D
polymorphism using polymerase chain reaction (PCR).
2.Methods
2.1. Subjects. One hundred and ten asthma patients partic-
ipated in this study. All patients were diagnosed between
December 2001 and September 2004 at the Kyung Hee
University Oriental Medical Center. The diagnosis of asthma
was conﬁrmed based on a clinical history with current
clinicalsymptoms suchas episodicwheezing, chesttightness,
dyspnea,and15%orgreaterreversibilityofforcedexpiratory
volume at one second (FEV1) spontaneously or after treat-
ment with a nebulized β2-agonist. Written informed consent
was obtained from each subject and all experiments were
conducted under protocols approved by the ethics review
committee of the Oriental Medical Research Institute at the
Kyung Hee University Medical Center.
2.2. Pulmonary Function Test. Pulmonary function was
tested using a Vmax 22 D Sensormedix (Sensormedix
Corporation, CA, USA) to measure the forced vital capacity
(FVC),FEV1 and peakexpiratory ﬂow rate (PEF).Resultsare
given as the percentage of the predicted values by Polgar and
Morris.
2.3. Determination of ESGA or DSGA. All patients were
diagnosed by TKM and then categorized into the DSGA or
the ESGA. Patients were asked whether they had any of 37
symptoms relevant to the TKM diagnosis for asthma. These
37 symptoms were then arranged into seven categories of
Table 1: Summary of criteria for DSGA and ESGA [13].
DSGA
Lung deﬁciency pattern
Paroxysmal cough, frequent breathing, weakness in voicea
Undertone and weakness in the sound of cougha
Sweating in daytimea, dryness of mouth, mild face ﬂush
Heart-kidney deﬁciency pattern
Asthmatic symptoms for more than 5 years, diﬃculty and
shortness of breath in inspirationa
Diﬃculty in breathing on movementa,f r e q u e n tf a t i g u e ,
swelling tendency and/or frequent urination,
Night sweatsa, cold hands and feet
Upper excess and lower deﬁciency pattern
Paroxysmalcough, excessive sputuma,d i ﬃculty in breathing
on movementa
Lumbago and/or cold low backa, cold hands and feet
Swelling tendency and/or frequent urination, palpitations
ESGA
External contraction of cold-wind pattern
Paroxysmal cough, watery sputum, white sputum, chillnessa
Headachea, generalized paina,n ot h i r s t
Phlegm-damp pattern
Paroxysmal cough, excessive sputum, viscous sputuma
Unpleasantness after expectoration, chest discomfort
Nauseaa, loss or reduction in appetitea
Cold-phlegm pattern
Exacerbation by cold weather or cold wind, watery sputum
White sputuma, foamy sputum, chest discomfort
Dark and bluish tone of facea, feeling of cold body and
preference for drinking warm watera
Phlegm-heat pattern
Frequent breathinga, high tone and coarseness in the sound
of cough
Viscous sputum, yellowish sputuma, chest discomfort
Flushed face with sweating, thirst for watera
DSGA, Deﬁciency Syndrome Group of Asthma; ESGA, Excess Syndrome
Group of Asthma.
aImportant symptoms for each pattern.
TKM patterns that each consisted of seven symptoms, with
some symptoms being assigned to more than one category
(Table 1)[ 13]. Each score of seven TKM was then calculated
by counting the number of symptoms checked in each
diagnostic category. Additionally, a score was determined for
each of three typical symptoms (Table 1)[ 13]i ne a c hg i v e n
diagnostic category. As a result, each diagnostic category
comprised seven symptoms, of which three symptoms had 2
points and the other four symptoms had 1 point. Therefore,
there was a possible total of 10 points for each diagnostic
category. Any categories that received a score of 5 points or
higher were considered to be relevant and the category with
the highest score was chosen for the diagnosis of a given
patient. If any categories had the same scores, an experienced
TKM doctor chose the most relevant diagnosis based onEvidence-Based Complementary and Alternative Medicine 3
Table 2: Clinical characteristics of the 110 Korean asthma patients and distribution of pulmonary functions in DSGA and ESGA.
Asthma patients (n = 110) DSGA (n = 60) ESGA (n = 50) P-value
Age (years) 49.9 ±17.15 0 .0 ± 16.24 9 .9 ± 18.3N S a
Sex (male/female) 49/61 31/29 18/32 NSb
Pulmonary functions
FVC predicted (%) 87.6 ±24.28 6 .2 ± 17.78 7 .6 ± 20.2N S a
FEV1 predicted (%) 77.5 ±24.27 6 .0 ± 23.07 8 .3 ± 26.5N S a
PEF predicted (%) 78.3 ±28.87 3 .7 ± 25.47 9 .1 ± 30.6N S a
Values are mean ± SD; DSGA, Deﬁciency Syndrome Group of Asthma; ESGA, Excess Syndrome Group of Asthma; FVC, forced vital capacity; FEV1,f o r c e d
expiratory volume at 1s; PEF, peak expiratory ﬂow rate; NS, no signiﬁcance.
aStudent’s t-test.
bChi-squared test.
Table 3: Distribution of allelic and genotypic frequency for ACE I/D polymorphism in Korean populations.
Allele frequency (%) Genotype frequency (%) HWE
N DI D / D I / D I / I P-value
DSGA 52 67 (64.42) 37 (35.58) 23 (44.23) 21 (40.38) 8 (15.38) .3908
ESGA 29 63 (67.02) 31 (32.98) 5 (17.24) 17 (58.62) 7 (24.14) .3377
P-value 0.7006a 0.0445b
Odds ratio (95% CI) 1.1223 (0.6232 −2.0211)
DSGA, Deﬁciency Syndrome Group of Asthma; ESGA, Excess Syndrome Group of Asthma; HWE, Hardy-Weinberg equation.
aChi-squared test with 2 ×2 contingency table.
bFisher’s test with 3 × 2 contingency table.
a close examination of the patient. The seven diagnoses were
then regrouped into two main categories, DSGA and ESGA.
Speciﬁcally, individuals that showed patterns consistent with
lungdeﬁciency,heart-kidneydeﬁciencyandupperdeﬁciency
and lowerexcess were categorizedasDSGA,whereas individ-
uals categorized as having an external contraction of cold-
wind pattern, phlegm-damp pattern, cold-phlegm pattern
and phlegm-heat pattern were categorized as ESGA.
2.4. ACE Gene Polymorphism Analysis. Peripheral blood
samples were obtained from 81 subjects and collected in
tubes containing ethylenediaminetetraacetic acid (EDTA).
Genomic DNA was extracted using a DNA isolation kit for
mammalian blood (Life Science & Biotech, Seoul, South
Korea). The sense oligonucleotide primer used for PCR was
5 -CTG GAG ACC ACT CCC ATC CTT TCT-3 ,a n dt h e
antisense primerwas 5 -GAT GTG GCC ATC ACA TTC GTC
AGA T-3  [14].Brieﬂy,100ngoftemplateDNAwereusedfor
eachPCRreaction,whichwasconductedunderthefollowing
conditions: 35 cycles of 94◦C for 45s, 60◦C for 50s, 72◦Cf o r
1min and aﬁnal extension at72◦Cfor10min. PCRproducts
were electrophoresed on 2% agarose gels and stained with
ethidium bromide to identify the following three possible
patterns (Figure 1): I/I (a 479bp fragment), D/D (a 191bp
fragment) and I/D (both 479 and 191bp fragments) (NCBI:
AF118569).
2.5. Statistical Analysis. All numerical variables are reported
as the mean ± standard deviation. Analyses were conducted
using SAS (Version 8.2. Cary, NC, USA). The diﬀerences
in the asthma patient’s ages and pulmonary functions were
comparedusing a Student’st-test, while genotypicand allelic
479bp
191bp
I/I I/D D/D
Figure1:ElectrophoresisofPCRproducts oftheACEgene.I;inser-
tion,D;deletion,I/I;insertionhomozygotes,I/D;insertion/deletion
heterozygotes, D/D; deletion type homozygotes.
frequencies were compared using a chi-squared test. Chi-
squared and Fisher tests were also used to determine if
the observed genotype frequency was in Hardy-Weinberg
equilibrium. A P-value of less than .05 was considered
statistically signiﬁcant for all analyses.
3.Results
3.1. Characteristics of Korean Asthma Patients. All 110
patients had participated in this study. They had signed the
informed consent form, tested pulmonary functions, and
asked whether they had any of 37 symptoms relevant to
TKM diagnosis for asthma. Of those 39 patients had refused
genotyping analysis, therefore 81 patients were analyzed
completely (Figure 2).
The characteristics of the 110 patients who were partici-
pated the pulmonary function test are presented in Table 2.
They are composed of 49 male and 61 female, with a mean4 Evidence-Based Complementary and Alternative Medicine
Table 4: Comparison of the frequency of ACE I/D polymorphism between male and female DSGA and ESGA patients.
Allele frequency (%) Odds ratio P-value
N D I (95% CI)
Male 33 39 (59.00) 27 (40.91) 0.9962 .9907a
Female 48 59 (59.00) 41 (41.00) (0.5295–1.8745)
Male
DSGA 19 23 (60.53) 15 (39.47) 1.15 .8051b
ESGA 14 16 (57.14) 12 (42.86) (0.4266–3.1000)
Female
DSGA 33 44 (66.67) 22 (33.33) 3.4545 .0043b
ESGA 15 11 (36.67) 19 (63.33) (1.4019–8.5125)
Genotype frequency (%) P-value HWE
N D/D I/D I/I P-value
Male 33 12 (36.36) 15 (45.45) 6 (18.18) .9605c .7311
Female 48 16 (33.33) 23 (47.92) 9 (18.75) .8852
Male
DSGA 19 8 (42.11) 7 (36.84) 6 (18.18) .5795d .3182
ESGA 14 4 (28.57) 8 (57.14) 2 (14.29) .5329
Female
DSGA 33 15 (45.45) 14 (42.42) 4 (12.12) .0126d .794
ESAG 15 1 (6.67) 9 (60.00) 5 (33.33) .2583
DSGA, Deﬁciency Syndrome Group of Asthma; ESG, Excess Syndrome Group of Asthma; HWE, Hardy-Weinberg equation.
aMale versus female using the chi-squared test with a 2 × 2 contingency table.
bDSGA versus ESGA sex distinction using the Fisher’s test with 2 × 2 contingency table.
cMale versus female using the chi-squared test with 3 ×2 contingency table.
dDSGA versus ESGA sex distinction using the Fisher test with 3 × 2 contingency table.
Recruiting patients of asthma
during study period (n = 110)
Diagnosis of asthma by
pulmonary function test (n = 110)
Determination of DSGA or ESGA
(n = 110)
Analyzed (n = 110)
Excluded from analysis (n = 0)
Sampling peripheral blood of
asthma patients (n = 81)
Analyzed (n = 81)
Excluded from analysis (n = 0)
Excluded (n = 39)
Refused to genotyping (n = 39)
Other reason (n = 0)
Figure 2: Diagram of study process.
age of 49.9 ± 17.1 years. Of those, DSGA include 60 patients
and ESGA was 50 patients. DSGA are composed of 31 male
and 29 female, and ESGA are composed of 18 male and 32
female
3.2. Pulmonary Function Test in DSGA and ESGA. Pul-
monary function test was performed in 110 asthma patients.
Of the patients evaluated in this study, 60 were DSGA
and 50 were ESGA. The mean FVC values were 87.6 ±
24.2, 86.2 ± 17.7a n d8 7 .6 ± 20.2f o rt h ee n t i r eg r o u p ,
DSGA patients and ESGA patients, respectively. The mean
FEV1 levels were 77.5 ± 24.2, 76.0 ± 23.0, and 78.3 ± 26.5
for the entire group, DSGA patients and ESGA patients,
respectively. The mean PEF values were 78.3 ± 28.8, 73.7 ±
25.4, and 79.1 ± 30.6 for all asthma patients, DSGA patients
and ESGA patients, respectively. None of these values
diﬀered signiﬁcantly between the DSGA and ESGA patients
(Table 2).
3.3. Association between ACE I/D Polymorphism and Korean
Asthma Patients. The observed genotype frequencies for the
ACE I/D polymorphism in these Korean asthma patients
are shown in Table 3. Of the 110 patients assessed using the
pulmonary function test, 39 were excluded from subsequent
evaluation because they refused to undergo genetic analysis.
Therefore, 81 patients were evaluated for the presence of the
ACE I/D polymorphism by PCR.
The allelic frequencies of ACE did not diﬀer signiﬁ-
cantly between the DSGA and ESGA groups (P = .7006,
OR = 1.1223). However, the genotypic frequency of ACE
diﬀered signiﬁcantly between the ESGA and DSGA groups
(P = .0445) (Table 3). The allelic and genotypic frequencies
of ACE did not diﬀer between male and female patients
(P = .9907 and P = .9605, resp.). In addition, there were no
signiﬁcant diﬀerencesintheallelicandgenotypicfrequenciesEvidence-Based Complementary and Alternative Medicine 5
of ACE of males in the ESGA and DSGA groups (P =
.8051 and P = .5795, resp.). However, the allelic and the
genotypicfrequenciesoftheACEI/Dpolymorphismdiﬀered
signiﬁcantly between DSGA and ESGA females (P = .0043,
OR = 3.4545 and P = .0126, resp.) (Table 4).
4.Discussionand Conclusion
Bronchial asthma is inﬂuenced by many environmental and
genetic factors [15]. One of the genetic factors believed to
play an important role in asthma is the ACE I/D polymor-
phism [16]. In the present study, bronchial asthma patients
were classiﬁed into the DSGA or ESGA group based on
theirdiﬀerentiation-syndrome,which isadiagnosticmethod
based on TKM theory. Deﬁciency syndrome is characterized
by a deﬁciency of genuine Qi, lowered body resistance
and declined function, including Yin and Yang deﬁciency.
Excess syndrome is characterized by stagnant Qi, raised body
resistance and excessive function, including Yin and Yang
excessiveness. DSGA includes patients with patterns of lung
deﬁciency, heart-kidney deﬁciency, and upper deﬁciency
and lower excess deﬁciency. Conversely, ESGA patients are
characterized by patterns of external contraction of cold-
wind, phlegm-damp patterns, cold-phlegm patterns and
phlegm-heat patterns (Table 1)[ 13]. Through diagnosis of
DSGA and ESGA, a TKM doctor can prescribe various
treatments for bronchial asthma.
DSGA and ESGA have been extensively studied in Korea.
Choi et al. [13] analyzed the therapeuticeﬀectsof treatments
prescribed based on criteria for Deﬁency-Excess Syndromes
of asthma. In addition, other studies have been conducted
to evaluate the eﬀects of Gamipaimo-tang on asthma
associated with excess syndrome [17], and the eﬀect of
Chuongsangboha-tang on asthma associated with deﬁciency
syndrome [18]. Furthermore, Yu et al. [19]r e p o r t e da n
association between the glutathione-s-transferase M1/T1
gene polymorphism and Deﬁciency-Excess diﬀerentiation.
In the present study, the clinical phenotypes of DSGA
and ESGA were not associated with the pulmonary function
t e s t .F u r t h e r m o r e ,n od i ﬀerences between DSGA and ESGA
patients were observed when the asthmatic patients were
categorized according to their distribution of ACE allelic
frequencies.Consequently,basedontheresultsofthecurrent
study, DSGA and ESGA do not appear to be related to
the degree of airway obstruction. A high prevalence of
ACE deletion polymorphisms were found in DSGA patients
(frequency of D > I allele in ESGA and DSGA, and the dis-
tribution rate of DD > ID > II genotype in DSGA) (Table 3).
In addition, the ACE allelic and genotypic frequencies were
found to diﬀer signiﬁcantly between females in the DSGA
and ESGA groups.
Many otherresearchers and practitionersof complemen-
tary and alternative medicine includingTKM doctorsunder-
stand that all-inclusive diagnostic approach is essential for
new perspectives and ideas to this developmental endeavor
[20].
In conclusion,the results of this study suggest that DSGA
and ESGA are signiﬁcant clinical phenotypes associated with
the ACE polymorphisms in Korean asthma patients. In
addition, these ﬁndings may provide a new approach to
investigation of the etiology of asthma.
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